ABBV AbbVie Inc

Price (delayed)

$110.86

Market cap

$195.72B

P/E Ratio

23.34

Dividend/share

$4.84

EPS

$4.75

Enterprise value

$274.89B

Sector: Healthcare
Industry: Drug Manufacturers - General

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate ...

Highlights

The company's net income has surged by 127% YoY and by 6% QoQ
The EPS has soared by 109% YoY
The quick ratio has contracted by 26% YoY but it has grown by 17% from the previous quarter
The debt has surged by 127% year-on-year
ABBV's P/E is 35% above its last 4 quarters average of 17.3 and 12% above its 5-year quarterly average of 20.9

Key stats

What are the main financial stats of ABBV
Market
Shares outstanding
1.77B
Market cap
$195.72B
Enterprise value
$274.89B
Valuations
Price to earnings (P/E)
23.34
Price to book (P/B)
12.81
Price to sales (P/S)
4.82
EV/EBIT
27.24
EV/EBITDA
18.32
EV/Sales
6.76
Earnings
Revenue
$40.65B
EBIT
$10.09B
EBITDA
$15.01B
Free cash flow
$15.33B
Per share
EPS
$4.75
Free cash flow per share
$8.66
Book value per share
$8.65
Revenue per share
$22.98
TBVPS
$18.19
Balance sheet
Total assets
$149.62B
Total liabilities
$134.33B
Debt
$87.06B
Equity
$15.27B
Working capital
-$1.17B
Liquidity
Debt to equity
5.7
Current ratio
0.95
Quick ratio
0.68
Net debt/EBITDA
5.28
Margins
EBITDA margin
36.9%
Gross margin
68.7%
Net margin
18.2%
Operating margin
28.5%
Efficiency
Return on assets
6.2%
Return on equity
205.2%
Return on invested capital
13.1%
Return on capital employed
8%
Return on sales
24.8%
Dividend
Dividend yield
4.37%
DPS
$4.84
Payout ratio
101.9%

ABBV stock price

How has the AbbVie stock price performed over time
Intraday
-0.36%
1 week
0.31%
1 month
7.84%
1 year
27.12%
YTD
3.46%
QTD
3.46%

Financial performance

How have AbbVie's revenue and profit performed over time
Revenue
$40.65B
Gross profit
$27.94B
Operating income
$11.57B
Net income
$7.38B
Gross margin
68.7%
Net margin
18.2%
The company's net income has surged by 127% YoY and by 6% QoQ
The net margin has surged by 84% year-on-year but it has declined by 5% since the previous quarter
The operating income has soared by 76% YoY and by 6% from the previous quarter
The operating margin rose by 43% year-on-year but it has declined by 6% since the previous quarter

Growth

What is AbbVie's growth rate over time

Valuation

What is AbbVie stock price valuation
P/E
23.34
P/B
12.81
P/S
4.82
EV/EBIT
27.24
EV/EBITDA
18.32
EV/Sales
6.76
The EPS has soared by 109% YoY
ABBV's P/E is 35% above its last 4 quarters average of 17.3 and 12% above its 5-year quarterly average of 20.9
AbbVie's equity has increased by 3.8% from the previous quarter
ABBV's revenue is up by 24% year-on-year and by 12% since the previous quarter
ABBV's P/S is 24% above its last 4 quarters average of 3.9 and 15% above its 5-year quarterly average of 4.2

Efficiency

How efficient is AbbVie business performance
The ROS has soared by 88% YoY but it has contracted by 4.2% from the previous quarter
AbbVie's return on assets has decreased by 13% QoQ but it has increased by 11% YoY
AbbVie's ROIC has increased by 12% YoY but it has decreased by 11% from the previous quarter

Dividends

What is ABBV's dividend history
DPS
$4.84
Dividend yield
4.37%
Payout ratio
101.9%
Recent dividends

Financial health

How did AbbVie financials performed over time
AbbVie's total assets is 11% higher than its total liabilities
The quick ratio has contracted by 26% YoY but it has grown by 17% from the previous quarter
ABBV's current ratio is down by 17% year-on-year but it is up by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.